Roles of salt‑inducible kinases in cancer (Review)

Shenghui Feng1, Fangyi Wei1, Haoran Shi1

  • 1Department of Gastroenterology, Research Institute of Digestive Diseases, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.

PubMed

Insights

Salt inducible kinases (SIKs) play complex roles in cancer, with subtypes SIK1, SIK2, and SIK3 exhibiting dual functions. This review explores their clinical value and therapeutic potential in oncology.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Salt inducible kinases (SIKs), comprising SIK1, SIK2, and SIK3, are ubiquitous AMP‑activated protein kinase family members.
  • SIK1 regulates adrenocortical function, SIK2 impacts cell metabolism (insulin signaling, gluconeogenesis), and SIK3 promotes cancer via mTOR.
  • Dysregulation of SIKs is prevalent in various cancers, with SIK1 often acting as a tumor inhibitor and SIK2/SIK3 as promoters.

Approach:

  • Comprehensive review of existing literature on SIK functions in cancer initiation and progression.
  • Analysis of contradictory roles of SIKs, challenging simple oncogene/tumor suppressor classification.
  • Elucidation of clinical value and potential therapeutic strategies targeting SIKs.

Key Points:

  • SIKs exhibit context-dependent roles in tumorigenesis, not fitting simple oncogene or tumor suppressor paradigms.
  • SIK1's function can be tumor suppressive, while SIK2 and SIK3 are frequently oncogenic.
  • The precise roles of SIKs vary significantly across different cancer types.

Conclusions:

  • SIKs represent a complex family of kinases with significant implications in cancer.
  • Understanding the nuanced functions of SIK subtypes is crucial for developing targeted cancer therapies.
  • Further research into SIKs may unlock novel therapeutic strategies for various malignancies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K